Retatrutide Before And After: What a Real Timeline Would Need

A retatrutide before and after already exists in published form, and it is not on a forum. It is the result of a phase 2 trial, and unlike almost every compound written about on sites like this one, that means the comparison worth making is not between an anecdote and nothing. It is between two records that share a name and were built in completely different ways.

One stage of that sequence has not happened. The trial ran and reported, but retatrutide is approved in no country, so neither of the two records below describes a drug anyone can lawfully be given.

Setting those two next to each other, stage by stage, is more useful than any general warning about internet photographs, because the trial version shows exactly what the personal version is missing and why each missing piece matters.

Two different things go by the name retatrutide before and after

The first is a published result: adults with obesity in a phase 2 trial reported in the New England Journal of Medicine in 2023 by Jastreboff and colleagues, with roughly 24 percent mean weight reduction at 48 weeks in the group receiving the highest dose studied, 12 mg. That is a before and after in the only sense that carries weight, a measured group compared against a comparison over a fixed period.

The second is a pair of photographs and a caption, posted by someone who bought a vial from a seller. It uses the same words and it is a different kind of object entirely.

The trap is that the first lends credibility to the second. A reader who knows there is real trial evidence will treat the forum post as an illustration of it. The post is not an instance of the trial. It is an unverified account of an unverified substance, and the existence of good evidence elsewhere does nothing to improve it.

The trial's version, in the order it was assembled

What makes the published result a before and after is the sequence in which it was constructed, and every step is deliberate.

Participants were screened first, against eligibility and exclusion criteria fixed in advance, which decided who was suitable and kept out people for whom the compound would have been a bad idea. Baseline measurements were then taken before anyone knew what they would receive, on standardised equipment, by staff following a protocol. Allocation followed, so that some participants received something other than the active compound and nobody chose their own group.

The endpoint and the week it would be read were written down before the first injection, which removes the option of measuring repeatedly and reporting the flattering moment. Participants attended scheduled visits and were measured the same way each time. Everyone enrolled was accounted for in the analysis, including those who stopped, which prevents the result being an average of the people it suited.

That order is the finding. The number people quote is downstream of it, and without the ordering the number would mean nothing.

The forum version, in the order it happens

Now the other sequence, which is shorter.

Someone reads about the compound and decides it is worth trying. They pay for a vial from a supplier with no verification of any kind. They begin, having already told at least one person and having already formed an expectation. There is no baseline beyond a photograph taken on the day they decided, usually at a low point, since low points are when people buy things.

Weeks pass. Other things change during those weeks, because they always do: eating differently because a decision has been made, more attention to what is on the plate, sometimes a new gym membership bought in the same week as the vial. A second photograph is taken on a day the person is pleased with what they see. It is posted, or it is not, and whether it is posted depends heavily on which of those two photographs looks better.

Nothing in that sequence is dishonest. It simply contains no step capable of separating the compound from everything else that happened.

The word mean, which does most of the damage

The published figure is a group average, and averages behave in ways that headline numbers hide.

Individual results in any trial spread around the mean. Some participants sit well above it and some well below, and the average carries no information about where any particular person would land. Read as a forecast it produces a specific and predictable disappointment, since roughly half of any group falls below its own average by definition.

There is a second and larger problem with using it as a personal expectation. The mean describes participants inside the whole trial arrangement: screened, supplied with a verified product, escalated under supervision, measured on schedule, with the same background support given to every group. It is a property of that arrangement, not of the molecule alone, and someone reproducing only the molecule has reproduced the least controllable part of it.

What a photograph cannot show

Even a genuine, unedited pair of images from a person who did exactly what they said is missing the things that would make it evidence.

It cannot show what was in the vial, which in an unregulated market is the first question rather than a detail. It cannot show what else changed during the period, and something always does. It cannot show what the person would have looked like without the compound, which is the comparison the whole exercise rests on. It cannot show the people who tried the same thing and posted nothing, and their absence is not random, since accounts of nothing much happening are written less, posted less and read less.

Lighting, posture, time of day and the direction of a camera account for more visible difference than most people assume, which is why the format is popular with sellers regardless of what is being sold.

There is one further absence, and it is the one that separates this compound from most things sold in the same way. The trial recorded harms as well as results, systematically, in participants who could report them at a scheduled visit. A photograph pair records neither. Whatever difficulty the person had in those weeks is either edited out of the caption or was never the kind of thing a picture holds, and the reader sees a result with the cost removed.

Why this page will not give a week by week expectation

It would be easy to convert the trial into a timeline of what to expect in each month, and several sites have done it. It would also be false.

The trial reported a measurement at a fixed point in a group. It did not publish a schedule of what an individual should see and when, and constructing one requires filling gaps with invention. Anything presented as a month by month expectation for this compound is either extrapolated from a group average or assembled from anecdotes, and in both cases the confidence in the presentation is entirely manufactured.

The compound is also unapproved everywhere, which means the person reading such a timeline would be applying it to a substance nobody has verified, without screening or monitoring. A timeline in that situation is not information, it is a script for ignoring what actually happens.